TB drug safety under the microscope: who is at risk for liver damage?
NCT ID NCT07472348
First seen Mar 21, 2026 · Last updated May 14, 2026 · Updated 7 times
Summary
This study tracks 220 adults being treated for tuberculosis (TB) or latent TB to see how often the drug isoniazid causes liver injury and what factors raise that risk. Researchers will review medical records from 2020 to 2028, looking at patient details, lab results, and how doctors manage any liver problems. No new treatments are tested; the goal is to learn from real-world care to make TB treatment safer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ASST Fatebenefratelli Sacco Hospital
Milan, Italy, 20157, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.